Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

This study has been completed.
Sponsor:
Collaborator:
PATH
Information provided by (Responsible Party):
Karen Kotloff, MD, University of Maryland
ClinicalTrials.gov Identifier:
NCT01531530
First received: October 26, 2011
Last updated: January 14, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)